... profit for the April-December period jumped, rising 24 percent to 96.4 billion yen, helped by strong sales of its high blood pressure medicine Benicar. ...
all 7 news articles
... formed when Sankyo bought Daiichi Pharmaceutical, posted a stronger climb in income on a jump in sales for its high blood pressure medicine Benicar. ...
... profit for the April-December period jumped, rising 24 percent to 96.4 billion yen, helped by strong sales of its high blood pressure medicine Benicar. ...
Namenda sales exceeded $200 million for the first time, while Lexapro also generated record sales and income from the Benicar(R) co-promotion remained ...
Azor is a trademark of Daiichi Sankyo, Inc.; Benicar and Benicar HCT are registered trademarks of Daiichi Sankyo, Inc.; and Campral is a registered ...
*Azor is a trademark of Daiichi Sankyo, Inc.; Benicar and Benicar HCT are registered trademarks of Daiichi Sankyo, Inc.; and Campral is a registered ...
... or 107 yen a share, a year earlier, the maker of the Benicar hypertension medicine said in a statement to the Tokyo Stock Exchange. ...
"Pretty much all of our profit gain can be attributed to Benicar," Ryoichi Watanabe, general manager of Daiichi Sankyo's accounting department, ...
all 20 news articles